This company is no longer in business. Investors can get details about any potential exits or failures here.

Eclipse Diagnostics

Eclipse Diagnostics

Early Stage

Grower-friendly cannabis test

Grower-friendly cannabis test

Overview

Raised this Round: Raised: $179,058

Total Commitments ($USD)

Platform

StartEngine

Start Date

04/10/2019

Close Date

04/29/2020

Min. Goal
$10,000
Max. Goal
$363,000
Min. Investment

$495

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$11.00

Pre-Money Valuation

$11,189,805

Year Founded

2018

Industry

Farming & Agriculture

Tech Sector

AgriTech

Distribution Model

B2B/B2C

Margin

High

Capital Intensity

High

Location

Los Angeles, California

Business Type

High Growth

Eclipse Diagnostics, the developer of a hand-held cannabis testing device, is raising funds on StartEngine. The company has a valuation of $11.1 million and has already launched a stroke-monitoring device in the past. Now, Eclipse Diagnostics is introducing Cannabinox, a device to test the levels of cannabinoids and other chemicals in plants. The device is easy to use, portable and has lab-grade accuracy. Eclipse Diagnostics was founded in 2018 by Dr. Luka Fajs and Prof. Robert S. Marks. The current crowdfunding round has a minimum raise of $10,000 and a maximum raise of $363,000 and will be used for further filed testing, FCC certification, and overall improvement of the device.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 04/10/2019
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Eclipse Diagnostics 04/28/2020 StartEngine $11,189,805 $179,058 Equity - Common Funded RegCF
Eclipse Diagnostics 10/30/2018 StartEngine $10,000,000 $171,750 Equity - Common Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Eclipse Diagnostics on StartEngine
Platform: StartEngine
Security Type: Equity - Common
Valuation: $11,189,805
Price per Share: $11.00

Follow company

Follow Eclipse Diagnostics on StartEngine

Buy Eclipse Diagnostics's Deal Report

Warning: according to the close date for this deal, Eclipse Diagnostics may no longer be accepting investments.

Eclipse Diagnostics Deal Report

Get KingsCrowd’s comprehensive report on Eclipse Diagnostics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Eclipse Diagnostics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Eclipse Diagnostics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge